Important indicator

Vereshchagin E.I.; Maksimova Yu.V.; Svechnikova E.V.; Artemyeva N.O.

Vereshchagin E.I.

Novosibirsk State Medical University

Maksimova Yu.V.

Novosibirsk State Medical University

ORCID: 0000-0002-9094-1714

Svechnikova E.V.

Medical Institute of Continuing Education of Rosbiotech;
Polyclinic No. 1 of Administrative Directorate of the President of the Russian Federation

Artemyeva N.O.

Novosibirsk State Medical University

Important indicator

Authors:

Vereshchagin E.I., Maksimova Yu.V., Svechnikova E.V., Artemyeva N.O.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2025;(4): 44‑47

Read: 221 times

Contact the author

Table of contents

To cite this article:

Vereshchagin EI, Maksimova YuV, Svechnikova EV, Artemyeva NO. Important indicator. Non Nocere. New Therapeutic Journal. 2025;(4):44‑47. (In Russ.)

Использование инфографики авторами научных работ

Abstract:

Uric acid as a criterion for assessing the severity of chronic systemic inflammation and the possibility of correcting its level.

Authors:

Vereshchagin E.I.

Novosibirsk State Medical University

Maksimova Yu.V.

Novosibirsk State Medical University

ORCID: 0000-0002-9094-1714

Svechnikova E.V.

Medical Institute of Continuing Education of Rosbiotech;
Polyclinic No. 1 of Administrative Directorate of the President of the Russian Federation

Artemyeva N.O.

Novosibirsk State Medical University

Close metadata

References:

Silveira Rossi JL, Barbalho SM, Reverete de Araujo R, Bechara MD, Sloan KP, Sloan LA. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors. Diabetes Metab Res Rev. 2022 Mar;38(3): e3502. https://doi.org/10.1002/dmrr.3502
Crowley SD. The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension. Antioxid Redox Signal. 2014 Jan 1;20(1):102-120. https://doi.org/10.1089/ars.2013.5258
Russo S, Kwiatkowski M, Govorukhina N, Bischoff R, Melgert BN. Meta-Inflammation and Metabolic Reprogramming of Macrophages in Diabetes and Obesity: The Importance of Metabolites. Front Immunol. 2021 Nov 5;12:746151. https://doi.org/10.3389/fimmu.2021.746151
De Pergola G, Cortese F, Termine G, et al. Uric Acid, Metabolic Syndrome and Atherosclerosis: The Chicken or the Egg, Which Comes First? Endocr Metab Immune Disord Drug Targets. 2018;18(3):251-259. https://doi.org/10.2174/1871530318666180212101548
Lanaspa MA, Sanchez-Lozada LG, Choi YJ, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -in- dependent fatty liver. J Biol Chem. 2012 Nov 23;287(48):40732-40744. https://doi.org/10.1074/jbc.M112.399899
Copur S, Demiray A, Kanbay M. Uric acid in metabolic syndrome: Does uric acid have a definitive role? Eur J Intern Med. 2022 Sep;103:4-12. https://doi.org/10.1016/j.ejim.2022.04.022
Raya-Cano E, Vaquero-Abellán M, Molina-Luque R, De Pedro-Jiménez D, Molina-Recio G, Romero-Saldaña M. Association between metabolic syndrome and uric acid: a systematic review and meta-analysis. Sci Rep. 2022 Nov 1;12(1):18412. https://doi.org/10.1038/s41598-022-22025-2
Lee MH, Graham GG, Williams KM, Day RO. A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients? Drug Saf. 2008;31(8):643-665. https://doi.org/10.2165/00002018-200831080-00002
Ma W, Cui C, Feng S, et al. Serum Uric Acid and Triglycerides in Chinese Patients with Newly Diagnosed Moyamoya Disease: A Cross-Sectional Study. Biomed Res Int. 2019 Jul 2;2019: 9792412. https://doi.org/10.1155/2019/9792412